- Home
- MTEK vs INDP Comparison
MTEK vs INDP Comparison
Compare MTEK & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEK
- INDP
- Stock Information
- Founded
- MTEK 2008
- INDP 2000
- Country
- MTEK Israel
- INDP United States
- Employees
- MTEK N/A
- INDP N/A
- Industry
- MTEK
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- MTEK
- INDP Health Care
- Exchange
- MTEK Nasdaq
- INDP Nasdaq
- Market Cap
- MTEK N/A
- INDP 6.0M
- IPO Year
- MTEK 2022
- INDP N/A
- Fundamental
- Price
- MTEK $3.39
- INDP $12.33
- Analyst Decision
- MTEK
- INDP Strong Buy
- Analyst Count
- MTEK 0
- INDP 2
- Target Price
- MTEK N/A
- INDP $238.00
- AVG Volume (30 Days)
- MTEK 117.5K
- INDP 698.8K
- Earning Date
- MTEK 08-27-2025
- INDP 08-11-2025
- Dividend Yield
- MTEK N/A
- INDP N/A
- EPS Growth
- MTEK N/A
- INDP N/A
- EPS
- MTEK N/A
- INDP N/A
- Revenue
- MTEK $6,078,953.00
- INDP N/A
- Revenue This Year
- MTEK N/A
- INDP N/A
- Revenue Next Year
- MTEK N/A
- INDP N/A
- P/E Ratio
- MTEK N/A
- INDP N/A
- Revenue Growth
- MTEK 50.80
- INDP N/A
- 52 Week Low
- MTEK $1.48
- INDP $7.56
- 52 Week High
- MTEK $6.47
- INDP $66.64
- Technical
- Relative Strength Index (RSI)
- MTEK 62.34
- INDP 54.68
- Support Level
- MTEK $3.00
- INDP $11.87
- Resistance Level
- MTEK $3.44
- INDP $13.40
- Average True Range (ATR)
- MTEK 0.24
- INDP 1.50
- MACD
- MTEK 0.01
- INDP 0.18
- Stochastic Oscillator
- MTEK 78.72
- INDP 76.44
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.